Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity
Glucagon-like peptide-1 receptor agonists (GLP-1RA) and bariatric surgery have proven to be effective treatments for obesity and cardiometabolic conditions. We aimed to explore the early metabolomic changes in response to GLP-1RA (liraglutide) therapy vs. placebo and in comparison to bariatric surgery.
Source: Metabolism - Clinical and Experimental - Category: Biomedical Science Authors: Angeliki M. Angelidi, Alexander Kokkinos, Despina Sanoudou, Margery A. Connelly, Andreas Alexandrou, Geltrude Mingrone, Christos S. Mantzoros Source Type: research
More News: Bariatric Surgery | Biomedical Science | Cardiology | Eating Disorders & Weight Management | Heart | Obesity | Victoza